Lancet and Pen Needles Market Research Report – Asia Pacific Forecast till 2023

Lancet and Pen Needles Market Research Report – Asia Pacific Forecast till 2023

ID: MRFR/MED/0187-HCRR | April, 2018 | Region: Global | 90 pages | Half-Cooked Research Reports

Lancet and Pen Needles Market Research Report, By Therapy (Insulin, (GLP-1), Growth Hormones), Gauge (17/18G, 21G, 23G), Needle Length (4mm, 8mm, 12mm), And End Users (Medical Institutions & Research Organizations) – The Asia Pacific Forecast till 2023 


Market Scenario:


Lancet and pen needles can be effectively used for the blood-based diagnosis, monitoring, and medication of diseases like diabetes and osteoporosis.  Pen needles are used in conjunction with the injection pens. Structurally, a pen needle consists of a hollow needle, which is embedded in a plastic hub and attaches to the injection pen. The lancet are double edged blades or needles and appears similar to the small scalpels. The market for lancet and pen needles is expected to grow at a healthy CAGR during the forecast period in the Asia Pacific region due to increasing prevalence of diseases like diabetes and osteoporosis. According to a study conducted by the American Diabetes Association in 2016, about 80% of the diabetic patients resides in the developing countries and it is estimated that the rise of type 2 diabetes in South Asia is likely to be 150% between 2000 and 2035. Moreover, in the Western Pacific region, the number of diabetic patients is expected to reach 201.8 million by 2035. Additionally, according to the International Osteoporosis Foundation by 2050, over ~50% of all osteoporotic hip fractures are expected to occur in Asia. Factors such as increasing geriatric population and growing healthcare expenditure along with favourable government policies are projected to boost the market growth during the forecast period.  However, the need to remove the pin after a single use and high cost as compared to the insulin vials may restrain the market growth during the forecast period. 

The Asia Pacific lancet and pen needles market is expected to grow at an approximate CAGR of 6.5% during the forecast period, 2017-2023. 


Intended Audience



  • Pharmaceutical companies

  • Biotechnological institutes

  • Government and Private Laboratories

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers 


Figure 1:- Asia Pacific lancet and pen needles market share, by end users

Asia Pacific lancet and pen needles market


Sources: WHO, annual reports, press release, white paper, and company presentation


 


Segmentation


The Asia Pacific lancet and pen needles market is segmented on the basis of therapy, gauge, needle length, and end users.


On the basis of the therapy, the market is segmented into insulin, glucagon-like peptide-1 (GLP-1), growth hormones, and others.


On the basis of the gauge, the market is categorized into 17/18G, 21G, 23G, and others.


On the basis of the needle length, the market is segmented into 4mm, 8mm, 12mm, and others.


On the basis of the end users, the market is segmented into hospitals & clinics, medical institutions & research organizations, and others.


 


Regional Analysis


On the regional basis, Asia Pacific is segmented into Japan, India, China, the Republic of Korea, Australia, and the Rest of Asia Pacific.

Japan holds a major share of the market followed by the Republic of Korea and Australia owing to the well-developed healthcare sector and high per capita healthcare expenditure. In 2014, according to the Statistics Bureau, Japan’s total medical care expenditure was about 11.20% of the national income, which accounted for USD 0.37 trillion. Additionally, favorable governmental policies boost the market growth in these regions.

China and India have a growing market due to huge population base, increasing demand for the better quality products, rapidly changing the economy, increasing healthcare expenditure, and rising number of pharmaceutical & biotechnological companies. Moreover, increasing number of healthcare organizations like a hospital, the private research institute has led to increasing in the market in India. Rest of Asia Pacific holds the least share of the market.

Research Methodology







Sources: WHO, annual reports, press release, white paper, and company presentation 


 


Key players for Asia Pacific lancet and pen needles market


Some of the key players in the Asia Pacific lancet and pen needles market are BD. (U.S.), Novo Nordisk A/S (Europe), Ypsomed (Europe), B. Braun Melsungen AG (Europe), HTL-STREFA (Europe), Terumo Corporation (Asia Pacific), Artsana S.p.A. (Europe), Owen Mumford Ltd. (Europe), and others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Asia Pacific Lancet and Pen Needles, by Therapy

6.1 Introduction

6.2 Insulin

Market Estimates & Forecast, 2017 – 2023

6.3 Glucagon-Like Peptide-1 (GLP-1)

Market Estimates & Forecast, 2017 – 2023

6.4 Growth Hormones

Market Estimates & Forecast, 2017 – 2023

6.5 Others

Chapter 7. Asia Pacific Lancet and Pen Needles, by Gauge

7.1 Introduction

7.2 17/18G

Market Estimates & Forecast, 2017 – 2023

7.3 21G

Market Estimates & Forecast, 2017 – 2023

7.4 23G

Market Estimates & Forecast, 2017 – 2023

7.5 Others

Chapter 8. Asia Pacific Lancet and Pen Needles, by Needle Length

8.1 Introduction

8.2 4mm

Market Estimates & Forecast, 2017 – 2023

8.3 8mm

Market Estimates & Forecast, 2017 – 2023

8.4 12mm

Market Estimates & Forecast, 2017 – 2023

8.5 Others

Chapter 9 Asia Pacific Lancet and Pen Needles, by End User

9.1 Introduction

9.2 Hospitals & Clinics

Market Estimates & Forecast, 2017 – 2023

9.3 Medical Institutions & Research Organizations

9.2.2 Market Estimates & Forecast, 2017 – 2023

9.4 Others

Chapter 10. Asia Pacific Lancet and Pen Needles, by Region

10.1 Asia Pacific

10.1.1 Japan

10.1.2 China

10.1.3 India

10.1.4 Australia

10.1.5 Republic of Korea

10.1.6 Rest of Asia Pacific

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 BD.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Novo Nordisk A/S

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Ypsomed

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 B. Braun Melsungen AG

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 HTL-STREFA

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Terumo Corporation

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Artsana S.p.A.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Owen Mumford Ltd.

12.8.1 Overview

12.8.2 Product Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Lancet and Pen Needles industry

Chapter 14 Appendix





LIST OF TABLES

Table 1 Lancet and Pen Needles Industry Synopsis, 2017-2023

Table 2 Asia Pacific Lancet and Pen Needles Market Estimates and Forecast, 2017-2023, (USD Million)

Table 3 Asia Pacific Lancet and Pen Needles Market by Region, 2017-2023, (USD Million)

Table 4 Asia Pacific Lancet and Pen Needles Market by Therapy, 2017-2023, (USD Million)

Table 5 Asia Pacific Lancet and Pen Needles Market by Gauge, 2017-2023, (USD Million)

Table 6 Asia Pacific Lancet and Pen Needles Market by Needle Length, 2017-2023, (USD Million)

Table 7 Asia Pacific Lancet and Pen Needles Market by End Users, 2017-2023, (USD Million)

Table 8 Japan Lancet and Pen Needles Market by Therapy, 2017-2023, (USD Million)

Table 9 Japan Lancet and Pen Needles Market by Gauge, 2017-2023, (USD Million)

Table 10 Japan Lancet and Pen Needles Market by Needle Length, 2017-2023, (USD Million)

Table 11 Japan Lancet and Pen Needles Market by End Users, 2017-2023, (USD Million)

Table 12 China Lancet and Pen Needles Market by Therapy, 2017-2023, (USD Million)

Table 13 China Lancet and Pen Needles Market by Gauge, 2017-2023, (USD Million)

Table 14 China Lancet and Pen Needles Market by Needle Length, 2017-2023, (USD Million)

Table 15 China Lancet and Pen Needles Market by End Users, 2017-2023, (USD Million)

Table 16 India Lancet and Pen Needles Market by Therapy, 2017-2023, (USD Million)

Table 17 India Lancet and Pen Needles Market by Gauge, 2017-2023, (USD Million)

Table 18 India Lancet and Pen Needles Market by Needle Length, 2017-2023, (USD Million)

Table 19 India Lancet and Pen Needles Market by End Users, 2017-2023, (USD Million)

Table 20 Republic of Korea Lancet and Pen Needles Market by Therapy, 2017-2023, (USD Million)

Table 21 Republic of Korea Lancet and Pen Needles Market by Gauge, 2017-2023, (USD Million)

Table 22 Republic of Korea Lancet and Pen Needles Market by Needle Length, 2017-2023, (USD Million)

Table 23 Republic of Korea Lancet and Pen Needles Market by End Users, 2017-2023, (USD Million)

Table 24 Rest of Asia Pacific Lancet and Pen Needles Market by Therapy, 2017-2023, (USD Million)

Table 25 Rest of Asia Pacific Lancet and Pen Needles Market by Gauge, 2017-2023, (USD Million)

Table 26 Rest of Asia Pacific Lancet and Pen Needles Market by Needle Lenght, 2017-2023, (USD Million)

Table 27 Rest of Asia Pacific Lancet and Pen Needles Market by End Users, 2017-2023, (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Asia Pacific Lancet and Pen Needles Market

Figure 3 Market Dynamics for Asia Pacific Lancet and Pen Needles Market

Figure 4 Asia Pacific Lancet and Pen Needles Market Share, by Therapy 2016

Figure 5 Asia Pacific Lancet and Pen Needles Market Share, by Gauge 2016

Figure 6 Asia Pacific Lancet and Pen Needles Market Share, by Needle Lenght 2016

Figure 7 Asia Pacific Lancet and Pen Needles Market Share, by End Users, 2016

Figure 8 Asia Pacific Lancet and Pen Needles Market Share, by Region, 2016

Figure 9 Asia Pacific Lancet and Pen Needles Market Share, by Country, 2016

Figure 10 Asia Pacific Lancet and Pen Needles: Company Share Analysis, 2016 (%)

Figure 11 BD.: Key Financials

Figure 12 BD.: Segmental Revenue

Figure 13 BD.: Geographical Revenue

Figure 14 Novo Nordisk A/S: Key Financials

Figure 15 Novo Nordisk A/S: Segmental Revenue

Figure 16 Novo Nordisk A/S: Geographical Revenue

Figure 17 Ypsomed: Key Financials

Figure 18 Ypsomed: Segmental Revenue

Figure 19 Ypsomed: Geographical Revenue

Figure 20 B. Braun Melsungen AG: Key Financials

Figure 21 B. Braun Melsungen AG: Segmental Revenue

Figure 22 B. Braun Melsungen AG: Geographical Revenue

Figure 23 HTL-STREFA: Key Financials

Figure 24 HTL-STREFA: Segmental Revenue

Figure 25 HTL-STREFA: Geographical Revenue

Figure 26 Terumo Corporation: Key Financials

Figure 27 Terumo Corporation: Segmental Revenue

Figure 28 Terumo Corporation: Geographical Revenue

Figure 29 Artsana S.p.A.: Key Financials

Figure 30 Artsana S.p.A.: Segmental Revenue

Figure 31 Artsana S.p.A.: Geographical Revenue

Figure 32 Owen Mumford Ltd.: Key Financials

Figure 33 Owen Mumford Ltd.: Segmental Revenue

Figure 34 Owen Mumford Ltd.: Geographical Revenue